Antibody-Binding Proteins and Conjugates
CAPRICO BIOTECHNOLOGIES INC ZAP-70 iFluor488 Antibody Conjugate
The ZAP-70 (IFluor488) Antibody Conjugate from Caprico Biotechnologies is an antibody that targets ZAP-70, a tyrosine kinase that plays a key role in T cell receptor signaling. This antibody is conjugated to IFluor488, a green fluorescent dye, allowing for direct detection of ZAP-70 expression via immunofluorescence. The antibody is made in rabbit and is supplied as a liquid in PBS with 0.1% sodium azide and 50% glycerol. The immunogen is a synthetic peptide from human ZAP-70. This antibody can be used for a variety of applications including Western blot, immunoprecipitation, immunofluorescence, and flow cytometry. It has been tested for use in human, mouse, and rat samples.
Cayman Chemical RaltegravIrpotasIum salt 50mg
Antigen full length human TRF2 Host goat Cross Reactivity human and mouse TRF2 Application(s) ChIP ICC IF IHC IP and WB TRF2 is a ubiquitously expressed protein that is implicated in the control of telomere length.
Cayman Chemical CItIcolInsodIum salt 50mg
An inhibitor of HDACs that preferentially inhibits HDAC1 (IC50 300 nM) over HDAC3 (IC50 8 M) does not inhibit HDAC8 induces p21/CIP1/WAF1 slowing cell growth differentiation and tumor development in vivo
Cayman Chemical ON-01910sodIum salt 25mg
A bicyclic CB analog with potent analgesic activity comparable or more potent than 9-THC in analgesic motor depressant anticonvulsant and hypothermic effects avidly binds the CB1 receptor (Ki 4.15 nM).
Cayman Chemical MonsInsodIum salt 500mg
A biguanide with diverse biological activities increases hepatic AMPK activity and reduces blood glucose by more than 50 in a liver kinase B1-dependent manner in mice fed normal and high-fat diets respectively and reduces blood glucose by 40 in ob/ob mice at 250 mg/kg reduces weight gain hepatic lipid droplet content and total cholesterol LDL cholesterol and triglyceride levels in the plasma of diet-induced obese mice at 10 or 50 mg/kg per day reverses increased hepatic triglyceride and apolipoprotein A5 levels as well as hepatic steatosis in an ob/ob mouse model of NAFLD reduces tumor growth in an HCT116 p53-\- mouse xenograft model at 250 mg/kg